⚡
Tingling & Paraesthesia Peripheral neuropathy · entrapment · cervical/lumbar radiculopathy · central causes · B12 · diabetes · MS
Progress 0 / 9

⚡ Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen ↗
1
Safety

Red Flags — Spinal Cord, Stroke & Rapidly Progressive Neuropathy

Paraesthesia with upper motor neurone signs, bilateral symptoms, or rapid progression = central or compressive cause until proven otherwise. Do not attribute to peripheral neuropathy without neurological examination.

Saddle anaesthesia or new urinary/bowel dysfunction, with or without bilateral leg tingling or weakness Cauda equina syndrome (lumbar disc or tumour compressing sacral roots) or spinal cord compression → 999. Emergency MRI spine the same day. Saddle anaesthesia (perineum, inner thighs) + any sphincter dysfunction = surgical emergency. Severe back pain with new bladder, bowel or sexual dysfunction, urinary retention, altered urinary sensation or saddle/perineal numbness → immediate assessment (NICE NG127).
Acute unilateral face, arm, or leg tingling with sudden onset TIA or ischaemic stroke — sensory cortex or thalamic lacunar infarct. Sudden-onset unilateral tingling or numbness may be vascular even without weakness. Use FAST and check glucose. Persistent symptoms → acute stroke pathway (999); resolved symptoms → offer aspirin 300 mg immediately unless contraindicated and refer for specialist assessment to be seen within 24 hours; advise not to drive (NICE NG128). Do not attribute sudden-onset unilateral tingling to peripheral neuropathy — central cause until excluded. If the patient is anticoagulated, has a bleeding disorder, or intracranial haemorrhage or another diagnosis is possible, seek urgent specialist advice rather than automatically giving aspirin.
Rapidly progressive ascending paraesthesia + weakness + areflexia Guillain-Barré syndrome — ascending demyelinating polyneuropathy, often post-infectious (Campylobacter, CMV, EBV). Paraesthesia starts in toes, ascends to trunk. Ask specifically about difficulty climbing stairs or rising from a chair, new falls or inability to walk, facial weakness, dysphagia/dysarthria, breathlessness, orthopnoea or weak cough, palpitations, postural symptoms or urinary retention. → Same-day hospital assessment (999 if bulbar/respiratory symptoms). Do not manage suspected GBS with outpatient nerve-conduction studies or wait for a fixed FVC threshold in primary care. IVIG and plasma exchange reduce severity and duration. Time-critical.
Paraesthesia + Lhermitte's sign (electric shock down spine on neck flexion) Spinal cord demyelination — multiple sclerosis (MS), cervical cord compression, B12 subacute combined degeneration of the cord. Lhermitte's sign is not pathognomonic for MS — it can occur with cervical cord demyelination, compression, B12 deficiency and other disorders. → Check B12 urgently; urgent neurology referral; imaging directed by examination findings.
Paraesthesia + weight loss + night sweats + lymphadenopathy Paraneoplastic neuropathy — sensory neuropathy as the presenting feature of an occult malignancy (lung SCLC, breast, ovarian, lymphoma). Do not routinely request anti-neuronal antibodies or tumour markers in primary care. → Urgent neurology referral; use the suspected cancer pathway where clinical features suggest an underlying malignancy (NICE NG12).
Tingling + ataxia + cognitive impairment in B12-deficient patient Subacute combined degeneration of the spinal cord (SACD) — B12 deficiency causing simultaneous posterior column (sensory) and lateral column (motor/corticospinal) degeneration. Irreversible if not treated promptly. Take diagnostic bloods before replacement where possible, but do not delay treatment (NICE NG239). B12 IM loading urgently (hydroxocobalamin 1 mg on alternate days until no further improvement, then every 2 months; check the SPC and local formulary). Do NOT give folic acid alone without checking B12 — folic acid can mask B12 deficiency while allowing neurological damage to progress.
Fever or systemic illness + back pain + neurological deficit Possible spinal infection or other acute cord pathology (including transverse myelitis) → same-day emergency assessment. New rapidly progressive neuropathy with autonomic instability (postural collapse, arrhythmia, urinary retention) → same-day hospital.
Warm, red or swollen foot in a person with diabetes or neuropathy Possible acute Charcot arthropathy (may be painless) or deep infection — especially with deformity or inability to weight-bear. If acute Charcot foot is suspected (redness, warmth, swelling or deformity, especially with neuropathy), advise non-weight-bearing and refer to the multidisciplinary foot care service within 1 working day (for triage within a further working day). Arrange a weight-bearing X-ray; consider MRI if the X-ray is normal but suspicion persists (NICE NG19). Limb- or life-threatening infection, ischaemia or gangrene → immediate acute referral. Foot ulcer with fever, sepsis or suspected deep infection → same-day hospital.
The anatomical localisation of paraesthesia is the most important clinical skill in managing this symptom — the distribution of tingling determines whether the cause is peripheral (nerve, root, plexus) or central (spinal cord, brainstem, thalamus, cortex). A GP who cannot localise the symptom neuroanatomically cannot safely manage paraesthesia. Key principles: (1) dermatome distribution = nerve root (radiculopathy) — e.g. C6 (thumb, index finger, lateral forearm), L5 (great toe, dorsum of foot, lateral calf); (2) peripheral nerve distribution = entrapment neuropathy — e.g. median nerve (thumb, index, middle, lateral half of ring finger — carpal tunnel), ulnar nerve (little and medial ring finger + medial hand); (3) stocking-and-glove distribution = length-dependent peripheral neuropathy (diabetes, alcohol, B12 deficiency); (4) one limb completely + face contralateral = brainstem; (5) all four limbs = spinal cord (above C5) or bilateral peripheral neuropathy; (6) one body half (hemisensory) = thalamus or cortex. Guillain-Barré syndrome is the most important acute paraesthesia emergency after stroke/TIA — it often follows a gastrointestinal or respiratory infection (Campylobacter jejuni most common, CMV, EBV, Zika, COVID-19), presenting 1–3 weeks after the infection with ascending tingling starting in the toes. The critical prognostic factor is respiratory compromise — the diaphragm and intercostal muscles can be affected, causing respiratory failure. In primary care, do not wait for a fixed FVC threshold — suspected GBS with weakness, bulbar or respiratory symptoms needs same-day hospital assessment. GPs who see a patient with ascending tingling + muscle weakness after a recent diarrhoeal illness must refer to hospital immediately.
2
Diagnose

Pattern Recognition — Localise the Lesion

Stocking-and-glove (length-dependent)
Both feet first (longest nerves affected first) → spreading proximally up legs, later hands. Implies: diffuse peripheral neuropathy. Most common causes: diabetes (most common worldwide), alcohol, B12 deficiency, CKD (uraemic neuropathy), hypothyroidism, paraproteinaemia, drugs (metronidazole, long-term nitrofurantoin, isoniazid, amiodarone, phenytoin, linezolid, chemotherapy, thalidomide, excess pyridoxine/vitamin B6 supplements; metformin and PPIs via B12 deficiency; statins — rare), nitrous oxide (including recreational use), hereditary (CMT disease), idiopathic. Investigate systematically.
Dermatomal (nerve root)
Specific anatomical band corresponding to a nerve root: C5 (lateral arm), C6 (thumb + lateral forearm), C7 (middle finger + dorsal forearm), C8 (little + ring finger + medial forearm), T1 (medial forearm), L4 (medial lower leg + ankle), L5 (dorsum foot + great toe), S1 (lateral foot + heel). Associated neck or back pain ± radiation. Coughing/sneezing worsens it. Cervical or lumbar radiculopathy. Objective weakness, gait disturbance, brisk reflexes or bladder/bowel symptoms increase urgency — MRI spine when examination indicates.
Peripheral nerve territory (mononeuropathy)
Median nerve (carpal tunnel): thumb + index + middle + lateral half of ring finger, worse at night, flicking the wrist relieves (Flick sign), Phalen's and Tinel's positive. Ulnar nerve (cubital tunnel): little + medial ring finger + medial hand, worse with elbow flexion. Radial nerve (Saturday night palsy): dorsal thumb + index + web space, associated wrist drop. Common peroneal nerve (foot drop): dorsum of foot + lateral lower leg — see the foot drop algorithm.
Bilateral hands AND feet simultaneously
Both upper and lower limbs simultaneously affected = systemic polyneuropathy (B12, alcohol, diabetes) OR spinal cord pathology (above C5). Distinguish by examination: UMN signs (hyperreflexia, upgoing plantars, clonus) = cord; absent reflexes + normal plantars = polyneuropathy. Any UMN sign = urgent neurology + MRI spine.
Face + limb (same or opposite side)
Ipsilateral face + contralateral limb tingling = brainstem lesion (lateral medullary syndrome, MS plaque, brainstem tumour). Hemibody (one entire half of body) = thalamic or cortical — stroke, MS, tumour. Perioral + bilateral hands tingling = hyperventilation (respiratory alkalosis → hypocalcaemia → tetany — check CO₂ and calcium).
Nocturnal, waking patient from sleep
Carpal tunnel syndrome: classic nocturnal tingling of median nerve distribution, relieved by shaking or dangling the hand. Also: ulnar nerve entrapment at elbow (if sleeping with elbow flexed). Meralgia paraesthetica (lateral femoral cutaneous nerve — outer thigh tingling, worsened by lying flat) — common in pregnancy, obesity, tight clothing. Peripheral vascular disease can mimic neuropathy at night.
Small-fibre vs large-fibre
Small-fibre: burning or shooting pain, thermal/pinprick abnormalities, allodynia, autonomic symptoms — power, reflexes, vibration and standard NCS may be normal; usually a specialist diagnosis after other causes are considered. Large-fibre: numbness, loss of vibration and joint position sense, sensory ataxia, positive Romberg, falls and impaired balance.
Multifocal, asymmetric, stepwise
Mononeuritis multiplex — typically asymmetric, painful and stepwise, affecting named nerves. Consider vasculitis with purpura, weight loss, fever, arthralgia, renal abnormalities, connective-tissue disease or rapidly progressive deficits. Do not order broad autoimmune testing for every sensory neuropathy — test and refer according to the clinical pattern.
History checklist
Exact onset, tempo and progression (episodic, persistent or fluctuating) · distribution · positive (burning, electric shocks, allodynia) and negative (numbness, loss of vibration/proprioception) symptoms · weakness, clumsiness, gait disturbance or falls · neck/back pain · bladder, bowel, sexual or saddle symptoms · bulbar or respiratory symptoms · autonomic symptoms (postural dizziness, sweating change, erectile dysfunction, early satiety) · diabetes, alcohol, renal, thyroid, autoimmune disease or malignancy · diet, veganism, gastric or ileal surgery · nitrous oxide · medicines and supplements · family history of neuropathy, pes cavus or “unusual feet” · occupational or toxic exposure · impact on sleep, walking, work and driving.
Length-dependent peripheral neuropathy is the most common pattern seen in primary care and reflects a fundamental neurobiological principle — the longest peripheral nerves (those supplying the toes and feet) are most susceptible to metabolic damage because they have the greatest distance over which axonal transport must maintain the distal axon. In diabetes, for example, chronic hyperglycaemia causes AGE (advanced glycation end-products) accumulation, oxidative stress, and polyol pathway dysfunction that impairs this axonal transport, affecting the longest nerves first. This is why diabetic peripheral neuropathy begins in both feet, symmetrically, before progressing to involve the legs and later the hands. Understanding this principle means a GP can immediately recognise that "tingling in one foot only" is unlikely to be diabetic neuropathy and requires localised investigation (nerve entrapment, lumbar radiculopathy). The Flick sign for carpal tunnel syndrome (median nerve distribution tingling that is relieved by vigorously shaking or flicking the wrist) is a useful bedside clue for CTS alongside Tinel's sign (percussion over the carpal tunnel) and Phalen's test (wrist flexion for 60 seconds). It was described by Pryse-Phillips in 1984 and validated in multiple studies. A patient who describes waking at night with tingling in the thumb and fingers and shaking their hand to relieve it has carpal tunnel syndrome until proven otherwise. The hyperventilation-tetany pattern (perioral tingling + bilateral hand tingling + carpopedal spasm) is important to recognise — it is caused by respiratory alkalosis from hyperventilation reducing ionised calcium, producing the sensory and motor manifestations of hypocalcaemia. It is distinct from true hypocalcaemia (which has the same symptoms but different cause) and is treated by addressing the hyperventilation pattern, not calcium supplementation.
3
Diagnose

Targeted Neurological Examination

Sensory examination
Light touch (cotton wool — spinothalamic anterior column) · Pinprick (spinothalamic — pain/temperature fibres, small fibre neuropathy) · Vibration sense (128 Hz tuning fork at great toe, malleolus, then knee — posterior column, large fibre) · Proprioception (joint position sense at toes, then ankles — posterior column) · Temperature (hot/cold test tubes — if vibration/proprioception normal but pain abnormal = small fibre neuropathy)
Motor and reflex examination
Power (MRC grading 0–5) in upper and lower limbs · Reflexes: biceps (C5/C6), supinator (C6), triceps (C7), knee (L3/L4), ankle (S1) · Plantar response (normal = downgoing; UMN = Babinski upgoing) · Clonus (sustained rhythmic contractions at ankle = UMN, spinal cord pathology) · Coordination (heel-shin, finger-nose — cerebellar, posterior column). Absent ankle jerks + upgoing plantars = subacute combined degeneration until proven otherwise.
Specific entrapment tests
Carpal tunnel: Tinel's (tap over flexor retinaculum → tingling in median distribution), Phalen's (wrist flexion 60 sec → tingling), Flick sign (shaking relieves), thenar wasting (advanced). Cubital tunnel (ulnar): elbow hyperflexion test (30 sec flexion → ulnar distribution tingling), hypothenar wasting. Meralgia paraesthetica: lateral thigh sensory loss/tingling, positive hip flexion test. Reproducing symptoms confirms entrapment.
Romberg's test
Stand with feet together, eyes open (normal) then closed. Positive = increased sway or falls with eyes closed but not open = posterior column dysfunction (proprioception loss) — B12 deficiency, tabes dorsalis, MS. Distinguish from cerebellar ataxia (unsteady with eyes open AND closed). Perform with adequate support. Positive Romberg = check B12; refer neurology for sensory ataxia (MRI directed by examination findings).
Spinal examination
Neck: flexion/extension ROM, Spurling's test (axial compression + lateral flexion towards affected side → radiculopathy), Lhermitte's sign. Lumbar: SLR (straight leg raise — L4/L5/S1 radiculopathy positive ≤60°), slump test, femoral stretch test (L2/L3/L4 — prone, flex knee, pain in anterior thigh). Document level of any radiculopathy sign clearly.
Foot examination
Inspect for skin breaks, blisters, fissures, infection, callus, nail disease, pes cavus, clawing, deformity, Charcot changes, foot temperature and colour, pedal pulses, and footwear inside and out. In diabetes use 10-g monofilament alongside vibration testing to detect loss of protective sensation — a foot-risk assessment, not a complete neurological examination.
Autonomic / falls
Gait and balance · sensory level · postural blood pressure where autonomic symptoms or falls are present · cranial nerves where indicated.
The combination of absent ankle jerks + extensor plantar responses (upgoing Babinski) is one of the most clinically important neurological sign combinations — it indicates simultaneous lower motor neurone (absent reflex = LMN at the peripheral nerve or anterior horn) and upper motor neurone (Babinski = UMN corticospinal tract) dysfunction. This combination occurs in three conditions: subacute combined degeneration of the spinal cord (B12 deficiency — posterior and lateral column degeneration), Friedreich's ataxia, and combined peripheral neuropathy with spinal cord compression. In primary care, the absent ankle jerks + upgoing plantars combination in a patient with tingling mandates immediate B12 measurement and urgent neurology referral. Thenar muscle wasting in carpal tunnel syndrome indicates advanced, long-standing disease with significant denervation — this finding should accelerate the referral to neurology/hand surgery for nerve conduction studies and surgical decompression consideration. Early carpal tunnel (tingling only, no wasting) can be managed conservatively with wrist splints. Wasting = nerve damage is occurring. The MRC muscle power scale (0 = no movement, 1 = flicker, 2 = movement with gravity eliminated, 3 = movement against gravity only, 4 = movement against resistance but reduced, 5 = normal) is the universal language for documenting neurological weakness. GPs should document power grades at every neurological examination — "power 4/5 in right ankle dorsiflexion" communicates much more than "some weakness in the right foot" and is the documentation standard expected in medicolegal review of neurological cases.
4
Diagnose

Investigations

First-line tests (persistent distal symptoms — NICE NG127)
HbA1c + fasting glucose (diabetes — most common cause of peripheral neuropathy) · B12 + folate (B12 deficiency — subacute combined degeneration; folate deficiency — peripheral neuropathy) · TSH (hypothyroid neuropathy — reversible) · FBC (macrocytic anaemia = B12/folate; normocytic = chronic disease; microcytic = iron) · U&E + eGFR (uraemic neuropathy, CKD) · ESR where clinically appropriate · Alcohol assessment (e.g. AUDIT-C) · Coeliac serology if clinically indicated
Additional targeted tests
Serum protein electrophoresis (SPEP) + immunoglobulins + serum free light chains (paraproteinaemia — for unexplained, progressive or atypical neuropathy) · LFTs + GGT (alcohol neuropathy) · Calcium (hypercalcaemia — sarcoidosis neuropathy) · CRP + ESR (vasculitic neuropathy — mononeuritis multiplex) · Autoimmune tests — ANA, ENA, ANCA, complement, RF only if vasculitis or connective-tissue disease is suspected · HIV, hepatitis B/C or Lyme serology only where risk factors or clinical features support testing · CK if myopathy possible · Heavy-metal testing only with a credible exposure history · MMA or homocysteine where B12 is indeterminate and suspicion persists
Imaging (directed by examination)
MRI spine for cord compression, sensory level, myelopathy or significant progressive radiculopathy · Brain imaging for acute focal symptoms or suspected central lesion · No routine MRI brain or spine for uncomplicated stable distal sensory neuropathy without localising signs · USS wrist or elbow (carpal tunnel confirmation — not routinely needed if clinical diagnosis clear)
Nerve conduction studies (NCS) / EMG
Arranged by neurology. NCS distinguishes: demyelinating (reduced conduction velocity — GBS, CIDP, CMT) vs axonal (reduced amplitude — diabetes, alcohol, toxic) neuropathy, confirms nerve entrapment location and severity (CTS — delays across carpal tunnel), identifies mononeuropathy multiplex (vasculitis). EMG (electromyography) adds motor unit analysis — denervation, reinnervation, myopathy. Useful for unexplained or progressive neuropathy, motor involvement, suspected CIDP or GBS, entrapment where surgery is being considered, and suspected hereditary neuropathy. Refer to neurology to arrange.
Skin biopsy (small fibre neuropathy)
NCS only tests large myelinated fibres — small fibre neuropathy (burning, tingling in feet, normal NCS) requires skin punch biopsy (intraepidermal nerve fibre density) or quantitative sensory testing (QST). Seen in: diabetes (early), chemotherapy-induced, Sjögren's, coeliac disease, amyloidosis, idiopathic. Specialist investigation — ordered by neurology.
Vitamin B12 interpretation (NICE NG239)
Avoid over-reliance on a single cut-off — use the laboratory reference range and clinical features. Take diagnostic samples before replacement where possible, but do not delay treatment if neurological features (especially suspected subacute combined degeneration). Consider MMA if indeterminate. Do not routinely repeat B12 during IM replacement; review symptoms and function at about 3 months, sooner if severe.
Do not routinely request
Tumour markers, anti-neuronal antibodies, MRI brain or MRI spine without localising signs.
B12 deficiency is the single most important reversible cause of peripheral neuropathy and spinal cord disease in primary care — the serum B12 level must be measured in every patient with unexplained paraesthesia, regardless of age. Reference ranges vary between laboratories, and serum B12 can be within or near the reference range in true functional deficiency — avoid over-reliance on a single numerical cut-off and interpret with clinical features (NICE NG239). If clinical suspicion is high despite normal serum B12, methylmalonic acid (MMA) and homocysteine are more sensitive markers of functional B12 deficiency (elevated MMA = B12 functional deficiency at cellular level). The interaction between folic acid and B12 in neuropathy management is a prescribing safety issue — folic acid supplementation in a patient with combined B12 and folate deficiency can cause haematological recovery (normalising the macrocytic anaemia) while the B12 deficiency neuropathy continues to progress and becomes irreversible. Always check B12 before prescribing folic acid. Always treat B12 deficiency with IM hydroxocobalamin before or concurrently with folic acid. The paraproteinaemia investigation (SPEP + serum free light chains) is important in unexplained peripheral neuropathy — a neuropathy can be caused by a paraprotein (IgM, IgG, or IgA monoclonal protein) from MGUS (monoclonal gammopathy of undetermined significance), multiple myeloma, or Waldenström's macroglobulinaemia. IgM paraproteinaemia is particularly strongly associated with peripheral neuropathy (anti-MAG antibodies in IgM MGUS cause a distinctive predominantly sensory, demyelinating neuropathy). Send SPEP and serum free light chains when the neuropathy is unexplained, progressive or accompanied by anaemia, renal impairment, hypercalcaemia, weight loss, bone pain or other myeloma features. For people aged 60 or over with persistent bone pain (particularly back pain) or unexplained fracture, NICE NG12 recommends FBC, calcium, ESR or plasma viscosity, SPEP and serum free light chains, with suspected cancer referral if results suggest myeloma.
5
Refer

Referral Pathways

999 / Same-day hospital
Ascending paraesthesia + progressive weakness → Guillain-Barré (respiratory compromise risk) · Saddle anaesthesia or new sphincter dysfunction, with or without bilateral leg symptoms → cauda equina (999) · Acute unilateral sensory deficit + FAST symptoms → stroke/TIA · Rapidly progressive bilateral weakness + sensory level → acute spinal cord compression or transverse myelitis · New inability to walk safely · Diabetic foot ulcer with fever, sepsis, ischaemia, suspected deep infection or gangrene
Urgent neurology (within 2 weeks)
Lhermitte's sign with other features of cord disease (not pathognomonic for MS) · Absent ankle jerks + upgoing plantars (subacute combined degeneration) · Brisk reflexes or other UMN signs · Progressive neuropathy with motor involvement · Suspected CIDP (progressive or relapsing symmetrical sensorimotor neuropathy >8 weeks, especially proximal weakness) · Suspected MND or hereditary neuropathy · Progressive peripheral neuropathy with normal first-line investigations · Mononeuritis multiplex (multiple separate nerve territories affected — vasculitis) · Suspected paraneoplastic neuropathy · New sensory ataxia
Routine neurology
Peripheral neuropathy with identified cause but requiring NCS/EMG for severity and monitoring · Unexplained peripheral neuropathy despite GP investigations · Hereditary neuropathy (CMT disease, family history) · Chronic sensory neuropathy stable but requiring diagnostic clarification · Suspected small-fibre neuropathy · Complex painful neuropathy not responding to treatment · Consideration of skin biopsy, autonomic testing, ganglioside antibodies or genetic testing (refer before genetic testing)
Podiatry / foot-protection service
Loss of protective sensation · Callus or deformity · Previous ulcer or amputation · Peripheral arterial disease · Active diabetic foot problems · Suspected Charcot arthropathy (refer to the multidisciplinary foot service within 1 working day — NICE NG19)
Hand surgery / orthopaedics
Carpal tunnel syndrome — surgical decompression if: failed conservative management (splinting × 6 weeks), wasting (thenar or hypothenar), severe pain, bilateral · Cubital tunnel — ulnar nerve transposition if failed conservative management or wasting · Trigger finger, de Quervain's tenosynovitis, other hand conditions causing paraesthesia
Spine surgery (neurosurgery / orthopaedic spinal)
Cervical radiculopathy with persistent pain or progressive weakness after 6 weeks conservative management · Lumbar radiculopathy with progressive weakness (not pain alone) · Spinal stenosis causing myelopathy (cord compression) · MRI-confirmed significant disc herniation with functional impairment
Endocrinology / haematology
Hypothyroidism — confirm biochemically and manage with levothyroxine per the thyroid guideline and local protocol; do not attribute neuropathy to mild biochemical abnormalities without clinical correlation. Diabetic neuropathy not responding to primary care management — diabetic specialist nurse/clinic. Paraprotein on SPEP → urgent haematology referral; suspected cancer pathway referral if results suggest myeloma — NICE NG12 (MGUS monitoring, myeloma exclusion: urine Bence Jones, bone marrow if CRAB criteria). B12 deficiency with neurological features (subacute combined degeneration) → haematology/neurology jointly.
The surgical referral threshold for carpal tunnel syndrome is based on the presence of thenar wasting — once the abductor pollicis brevis (the thenar muscle innervated exclusively by the median nerve) shows wasting, axonal degeneration of the median nerve is occurring and decompression surgery is indicated regardless of symptom duration. In contrast, mild CTS (tingling only, no wasting, normal sensation) can be managed conservatively: nocturnal wrist splint (neutral position splint, worn at night — treats the nocturnal component which is caused by wrist flexion during sleep), corticosteroid injection (methylprednisolone 40 mg or triamcinolone 10–20 mg into the carpal tunnel), ergonomic modifications. The BSSH/GIRFT adult carpal tunnel pathway (2022) lists night splinting, a single corticosteroid injection and nerve/tendon glides as non-operative first-line options before surgery. Mononeuritis multiplex (the simultaneous or successive involvement of multiple separate named peripheral nerves — e.g. right ulnar + left femoral + right sural) is a neurological pattern that is almost always caused by vasculitis (polyarteritis nodosa, Wegener's granulomatosis, rheumatoid vasculitis, SLE, cryoglobulinaemia, diabetic amyotrophy) or sarcoidosis, and occasionally by diabetic amyotrophy. It is typically asymmetric, painful and stepwise, and nerve damage can be rapid. Test according to the clinical pattern (e.g. ESR, CRP and targeted autoimmune tests where vasculitis is suspected) and refer urgently to neurology.
6
Treat

Treatment of Neuropathic Pain & Specific Causes

Treat the underlying cause first. Numbness without pain does not require a neuropathic analgesic. For painful neuropathy NICE CG173 offers a choice of amitriptyline, duloxetine, gabapentin or pregabalin — select by comorbidity, renal function, frailty, falls risk, sleep, mood and misuse risk; switch if ineffective or not tolerated at an adequate dose. Avoid routine combination therapy unless advised by a specialist. Tramadol only as short-term rescue; do not start strong opioids routinely. Capsaicin cream may be considered for localised pain when oral treatment is unsuitable or declined. All may impair driving; taper rather than stop abruptly.

Painful neuropathy — CG173 option
Amitriptyline 10 mg nocte
Titrate by 10 mg every 2 weeks to 25–75 mg nocte. One of four NICE CG173 options. Sedating, falls risk, overdose toxicity — take 2 hours before bed. Anticholinergic side effects (dry mouth, constipation, urinary retention — avoid in prostatism). Contraindicated: recent MI, arrhythmia, QTc prolonged. ECG if cardiac history.
Painful neuropathy — CG173 option (SNRI)
Duloxetine 60 mg OD
Usual adult dose (SPC) for diabetic peripheral neuropathic pain: 60 mg once daily (maximum 120 mg daily in divided doses); consider a lower starting dose if nausea or tolerability is a concern. Licensed for diabetic peripheral neuropathic pain (DPNP). NICE CG173. Useful if amitriptyline poorly tolerated or depression comorbid. SNRI — monitor BP, do not stop abruptly (discontinuation syndrome).
Painful neuropathy — CG173 option (gabapentinoid)
Pregabalin 75 mg BD
Titrate to 150–300 mg BD. Schedule 3 CD (controlled drug) — CD prescription requirements apply (valid 28 days; no repeat dispensing). Assess misuse risk carefully if there is a history of substance misuse (caution, not an absolute bar). Alternative: gabapentin 300 mg nocte increasing to 300–600 mg TDS (also Schedule 3 CD). Warn: dizziness, somnolence, weight gain, peripheral oedema, dependence, and respiratory-depression risk especially with opioids or other CNS depressants. Do not stop abruptly.
B12 deficiencyHydroxocobalamin 1000 mcg IM loading: if neurological features → 1 mg on alternate days until no further improvement, then every 2 months; without neurological features → 1 mg 3 times a week for 2 weeks. Maintenance: 1000 mcg IM every 2 months if neurological involvement; otherwise every 2–3 months — lifelong if pernicious anaemia or malabsorption. Oral cyanocobalamin for diet-related deficiency only (dose per SPC and local formulary) — NOT for pernicious anaemia; where other malabsorptive causes are treated orally, at least 1 mg daily (NICE NG239). Lifelong IM treatment with autoimmune gastritis, total gastrectomy or complete terminal ileal resection. Neurological improvement may take 3–6 months — review symptoms and function; do not routinely repeat B12 during IM replacement (NICE NG239).
Diabetic neuropathyIndividualise glycaemic targets per NICE NG28/NG17 (no universal HbA1c <48 mmol/mol neuropathy target); optimise cardiovascular risk and renal protection. Tight BP control (ACE inhibitor — nephroprotective and neuroprotective). Foot care education (see Lifestyle step). Neuropathic pain management as above. Choose among CG173 options by comorbidity (e.g. duloxetine if comorbid depression). Diabetic foot-risk assessment and foot-care advice; refer active diabetic foot problems per NICE NG19.
Carpal tunnelNocturnal wrist splint (neutral position) — first 6 weeks. Corticosteroid injection (methylprednisolone 40 mg + 1 ml lidocaine — a non-operative first-line option per BSSH/GIRFT 2022). Ergonomic wrist splint at work if occupational cause. Avoid activities requiring sustained wrist flexion. Refer hand surgery if: wasting, severe symptoms, bilateral, symptoms persisting or recurring after a single injection (BSSH/GIRFT), pregnancy CTS not resolving post-partum.
Alcohol neuropathyAlcohol reduction or abstinence is the most important intervention — address dependence safely (abrupt withdrawal may be dangerous) and offer alcohol-service referral. Neurological recovery, if it occurs, may be slow and incomplete. Thiamine 100 mg TDS orally for 3 months (nutritional replacement). If Wernicke's risk (confusion + ataxia + nystagmus) → emergency hospital assessment for parenteral thiamine per local protocol (e.g. Pabrinex IV), before or alongside glucose — never delay treatment of hypoglycaemia. Balanced diet. AUDIT score + alcohol liaison referral. B12, folate replacement if deficient.
NICE CG173 (Neuropathic Pain in Adults, 2013, updated 2020) recommends amitriptyline, duloxetine, gabapentin, and pregabalin as the four first-line options for peripheral neuropathic pain, with the choice guided by individual patient factors. Amitriptyline has the longest evidence base and is the cheapest (off-patent TCA), but carries anticholinergic risks in older patients (urinary retention, confusion, falls from orthostatic hypotension). Duloxetine is licensed for diabetic peripheral neuropathic pain and may suit people with comorbid depression; NICE does not set a fixed first-, second- or third-line sequence. Pregabalin and gabapentin are equally effective but are now Class C, Schedule 3 controlled drugs in the UK (since April 2019) due to misuse concerns — prescriptions must meet controlled-drug prescription requirements, and a history of opioid, benzodiazepine or gabapentinoid misuse calls for careful risk assessment and monitoring. The B12 dosing distinction is critical — the loading regimen for B12 deficiency with neurological features is more intensive than the standard regimen: 1000 mcg hydroxocobalamin IM on alternate days until no further improvement, rather than the fixed 3 injections a week for 2 weeks (6 doses) used for deficiency without neurological involvement. This more intensive loading is used because the window for preventing permanent cord damage is time-sensitive. Maintenance thereafter is every 2 months with neurological features (vs every 2–3 months without). Thiamine before carbohydrates in alcohol-related presentations is the Wernicke's encephalopathy prevention rule — administering IV glucose to a thiamine-depleted patient precipitates acute Wernicke's encephalopathy by rapidly depleting the last reserves of thiamine needed for glucose metabolism in the brain (specifically the mammillary bodies, thalamus, and oculomotor nuclei). Any patient who is intoxicated, malnourished, or acutely unwell from alcohol excess should receive high-dose parenteral thiamine (e.g. Pabrinex IV) before or alongside glucose where feasible — but emergency treatment of hypoglycaemia must never be delayed.
7
Treat

Radiculopathy & Central Causes

Cervical / lumbar radiculopathy
Many improve with conservative management. Analgesia: NSAID first after individual risk assessment, considering gastroprotection, for the shortest time (ibuprofen 400 mg TDS or naproxen 500 mg BD); do not offer paracetamol alone. Acute pain only, if an NSAID is contraindicated, not tolerated or ineffective: short-term weak opioid (codeine 30 mg QDS PRN). Lumbar radiculopathy (sciatica): no gabapentinoids, other antiepileptics, oral corticosteroids or benzodiazepines (NICE NG59). Cervical radiculopathy with a burning/shooting component: neuropathic agent per NICE CG173. Physiotherapy referral for specific nerve root exercises, McKenzie technique for lumbar, cervical traction.
Corticosteroid injection
Epidural steroid injection for acute lumbar radiculopathy with severe uncontrolled pain — arranged via spinal pain clinic or neurosurgery. Provides short-term pain relief, allowing mobilisation and physiotherapy. Does not alter long-term outcome but improves short-term function. Transforaminal approach preferred (fluoroscopy-guided).
MS-related paraesthesia
Acute relapse affecting function (confirmed by the MS team): offer oral methylprednisolone 0.5 g daily for 5 days; consider IV 1 g daily for 3–5 days if oral has failed or is not tolerated, or admission is needed (NICE NG220). Speeds recovery, does not alter long-term disability. Liaison with MS specialist nurse and neurology team. Disease-modifying therapy (DMT) — specialist initiated. Lhermitte's — no specific treatment needed; usually self-limiting. Gabapentin or amitriptyline for chronic neuropathic pain in MS.
Drug-induced neuropathy
Review the indication and alternatives rather than automatically stopping a medicine. Metronidazole: review exposure. Stop excess pyridoxine (vitamin B6) supplements. Amiodarone, phenytoin, linezolid and other suspected causes: discuss with the relevant specialist where necessary. Isoniazid: give pyridoxine (vitamin B6) co-prescription to prevent INH neuropathy (NICE NG33, 2016; prophylactic dose per NICE/SPC, usually 10 mg OD). Long-term nitrofurantoin: review within the recurrent-UTI plan. Chemotherapy-related neuropathy: discuss with oncology. Statin neuropathy: very rare — review risks and benefits with the patient before any change.
Meralgia paraesthetica
Lateral femoral cutaneous nerve compression at the inguinal ligament (L2/L3). Causes: obesity, pregnancy, tight belts/clothing, prolonged standing. Symptoms: burning, tingling, numbness of outer thigh — no motor deficit. Management: weight loss (most effective), loose clothing, avoid prolonged standing, NSAIDs. Corticosteroid injection at the ASIS (anterior superior iliac spine) may help. Surgery (nerve decompression or neurectomy) if refractory.

Next steps: see Neuropathic pain · Carpal tunnel syndrome · Sciatica · Stroke and TIA

The isoniazid-pyridoxine co-prescription rule is a prescribing safety principle that is commonly neglected in primary care — isoniazid (INH) competitively inhibits pyridoxine (vitamin B6) metabolism and can cause a peripheral neuropathy in patients not receiving pyridoxine supplementation, through depletion of pyridoxal-5-phosphate, which is essential for peripheral nerve axonal integrity. NICE NG33 (2016) pairs isoniazid with pyridoxine in its TB regimens (pyridoxine dose per NICE/SPC). Patients who develop peripheral neuropathy on isoniazid while not receiving pyridoxine have experienced a preventable iatrogenic injury. The McKenzie method for lumbar radiculopathy (extension exercises — "press-ups" from a prone position) is evidence-based physiotherapy for posterolateral disc prolapse causing radiculopathy — it works by using lumbar extension to centralise the disc herniation (pushing the nucleus pulposus anteriorly away from the nerve root). It is most effective when performed early (<6 weeks), repeated frequently (>10 repetitions × 5 times daily), and combined with directional preference assessment by a trained McKenzie physiotherapist. GPs referring for physiotherapy for back pain + radiculopathy should specify "McKenzie-trained physiotherapist for lumbar radiculopathy" rather than generic physiotherapy to ensure the appropriate technique is applied. The 6-week conservative management rule for cervical and lumbar radiculopathy reflects the natural history — many radiculopathy episodes from disc herniation improve with conservative management. Surgery is indicated for progressive neurological deficit (muscle wasting, power <4/5), sphincter involvement, or failure to improve after 6 weeks of adequate conservative management.
8
Lifestyle

Modifiable Risk Factors & Self-Management

Glycaemic control (diabetic neuropathy) Individualise glycaemic targets per NICE NG28/NG17 — no universal neuropathy HbA1c target. Annual diabetic foot screen (10-g monofilament + vibration testing) in primary care. Refer to diabetic podiatry if loss of protective sensation detected — foot ulcer prevention is the primary clinical goal. Annual screening is distinct from urgent assessment of active ulcers, ischaemia or suspected Charcot foot (NICE NG19).
Alcohol cessation Alcohol neuropathy: reduction or abstinence is the most effective treatment — address dependence safely, as abrupt withdrawal may be dangerous. Neurological recovery, if it occurs, may be slow and incomplete. No specific pharmacological neuropathy treatment beyond cessation + thiamine replacement. Involve alcohol liaison nurse, SMART Recovery, Alcoholics Anonymous, or community alcohol team as appropriate. Screen all patients with neuropathy for alcohol use (AUDIT).
Foot care (peripheral neuropathy) Loss of protective sensation = major fall and ulceration risk. Daily foot inspection (use a mirror or ask a family member to check soles). Check footwear for stones, foreign bodies before putting on. No barefoot walking. Avoid hot-water bottles, foot spas and direct heat (burns without feeling it). Do not self-cut corns or calluses or use corn plasters. Seek same-day advice for any break in the skin, blister, colour change, swelling or discharge. A warm, red or swollen foot may be acute Charcot arthropathy even without pain — foot-service assessment within 1 working day (NICE NG19). Fitted footwear from orthotics if deformity. Podiatry referral. NHS Diabetes foot care pathway.
Ergonomic modification (entrapment neuropathy) Carpal tunnel: avoid sustained wrist flexion (repetitive keyboard work, sleeping on flexed wrist). Ergonomic keyboard and mouse. Neutral wrist splint at night and during aggravating activities. Regular breaks from repetitive hand use. Cubital tunnel: avoid prolonged elbow flexion (phone use, sleeping), pad elbow. Meralgia paraesthetica: loose waistbands, avoid prolonged standing, lose weight if overweight.
Posture and back care (radiculopathy) Avoid prolonged sitting without breaks. Lumbar support roll for car and desk sitting. Core strengthening exercises (physiotherapy-directed). Sleep position: side-lying with pillow between knees for lumbar radiculopathy. Avoid lifting with bent spine. Smoking cessation — smoking impairs disc nutrition (avascular structure) and accelerates degenerative disc disease.
Vitamin B12 dietary sources B12 found exclusively in animal products: meat, fish, eggs, dairy, shellfish. Vegans and strict vegetarians require lifelong B12 supplementation. Fortified foods (plant milks, cereals). Oral cyanocobalamin (dose per SPC and local formulary) treats diet-related B12 deficiency in vegans with normal gut absorption. Advise all vegan and vegetarian patients to ensure adequate B12 intake — this is a preventable cause of irreversible neurological damage.
Falls prevention (sensory neuropathy) Loss of joint position sense and vibration sense = high falls risk. Occupational therapy home assessment. Remove hazards (loose rugs, poor lighting). Bathroom: grab rails, shower seat, non-slip mat. Footwear: well-fitting, closed-toe, flat heel. Mobility aid if needed (stick → frame). Refer to falls prevention service (NHS Ageing Well). Balance exercises (e.g. Otago programme).
Sleep hygiene (nocturnal symptoms) Carpal tunnel, peripheral neuropathy, and restless legs are all worse at night, disrupting sleep. Neutral wrist splint at night for CTS. Elevation of feet (pillow under lower legs) — reduces nocturnal neuropathic symptoms in peripheral neuropathy. Amitriptyline nocte: dual benefit of neuropathic pain relief + sedation for sleep disturbance. Avoid caffeine after noon. Consistent sleep schedule reduces sleep deprivation-amplified pain perception.
The diabetic foot care pathway is one of the most evidence-based and most impactful preventive interventions in all of primary care — most lower limb amputations in people with diabetes are preceded by a foot ulcer. Annual monofilament testing (10-g Semmes-Weinstein monofilament at 10 sites on each foot) identifies patients who have lost protective sensation (cannot feel the filament at ≥4 sites = risk foot), who are at highest risk of ulceration and require: specialist podiatry, prescription footwear assessment, patient education about foot inspection, and an emergency protocol if a foot wound is identified (urgent same-day diabetic foot clinic if any break in skin, redness, swelling, or skin temperature increase). The Otago Exercise Programme for falls prevention in older adults with sensory neuropathy is one of the most rigorously evidence-based community interventions available — it is a home-based balance and strength training programme developed in New Zealand and validated in multiple RCTs. It consists of 17 exercises (leg strengthening + balance exercises) performed 3 times/week, delivered by a physiotherapist initially then independently. NHS falls prevention services (typically within community physiotherapy) deliver the Otago programme — GPs should refer proactively when loss of proprioception or vibration sense is identified on examination.
9
Safety

Follow-Up, Monitoring & Safety-Netting

2–4 weeks after starting/changing medication; 4–8 weeks for response
Sedation, falls, dizziness and postural symptoms, BP if on duloxetine, oedema or weight gain, renal dosing, driving and occupational safety. At 4–8 weeks: pain response and functional benefit, sleep and walking, adverse effects — continue, switch or stop. Symptom progression (worse = escalate investigation/referral). Physiotherapy commenced? Blood test results reviewed (all results back?). Splint compliance (carpal tunnel). Podiatry referral outcome (diabetic neuropathy). Document neurological signs at each visit — changes inform referral urgency.
3 months
Peripheral neuropathy: treatment response (VAS or NRS pain score). Neuropathic medication: effective? Side effects? Escalate dose or switch if inadequate. Carpal tunnel: response to splint/injection — if not improved after a single injection or wasting present → refer hand surgery urgently. B12 deficiency: review symptoms and function (do not routinely repeat B12 during IM replacement — NICE NG239). Functional status: daily activities, driving, work.
Ongoing (chronic peripheral neuropathy)
Annual review: neurological pattern and progression, motor involvement, pain score, functional assessment, medication burden and deprescribing where appropriate. Foot examination at every diabetic annual review (monofilament + vibration). NCS repeated if significant progression. Driving: DVLA notification required if peripheral neuropathy significantly affects vehicle control — patient must notify DVLA if neuropathy in lower limbs affects ability to control pedals or brakes safely. Document advice given.
Investigation result review
All blood results reviewed within 1 week. MRI results within 2 weeks — any unexpected finding (spinal cord lesion, cerebral infarct, demyelinating plaque, tumour) → urgent neurology referral regardless of symptoms. SPEP/paraprotein positive → urgent haematology referral; suspected cancer pathway if results suggest myeloma — NICE NG12 (CRAB criteria: hyperCalcaemia, Renal failure, Anaemia, Bone lesions — myeloma screen).
999 / Same-day safety-net
999: new saddle or genital numbness, or new bladder or bowel change → cauda equina · Breathlessness, weak cough or swallowing difficulty with numbness or weakness (GBS) · Sudden one-sided numbness, face droop, arm weakness or speech change (stroke/TIA) · Same-day hospital: new bilateral leg weakness in any patient under follow-up for paraesthesia · Ascending weakness or rapidly ascending numbness (GBS) · New inability to walk safely (acute cord compression) · Same-day foot assessment: any foot ulcer, blister, colour change, warmth, swelling or discharge
Urgent GP same week
Rapidly worsening symptoms despite conservative treatment · New neurological sign at follow-up examination (new weakness, new reflex loss, new UMN sign) · Patient unable to tolerate neuropathic medication and in severe pain · Suspected drug-induced neuropathy (review indication and alternatives with the prescriber; document)
The DVLA notification requirement for peripheral neuropathy affecting driving is a medicolegal obligation that GPs must advise patients about and document — the DVLA medical standards for driving specify that any condition significantly affecting vehicle control requires notification. For lower limb neuropathy: if the patient cannot safely control the foot pedals (accelerator, brake, clutch) due to sensory loss or motor weakness, they must notify DVLA. Failure to notify DVLA and continued driving is illegal and voids the patient's insurance. The GP must advise the patient to notify DVLA, and should document this conversation in the medical record. If the patient refuses to stop driving when medically unsafe to do so, GMC confidentiality guidance (2017) says the doctor should contact the DVLA medical adviser directly, after telling the patient. The MRI unexpected finding protocol is important — GPs who request MRI spine for radiculopathy may receive reports containing unexpected findings (incidental meningioma, Chiari malformation, spinal cord lesion, unexpected vertebral metastasis, aortic aneurysm, adrenal lesion). Any unexpected significant finding requires: prompt review of the report, urgent specialist referral appropriate to the finding, and timely communication with the patient. A system for reviewing all imaging reports within 2 weeks of ordering is a clinical governance requirement — many serious diagnoses are made on incidental imaging findings, and the responsibility for acting on these lies with the requesting clinician.
Educational use only. Based on NICE NG127 (Suspected neurological conditions), NICE NG128 (Stroke and TIA), NICE NG19 (Diabetic foot problems), NICE NG239 (Vitamin B12 deficiency), NICE NG59 (Low back pain and sciatica), NICE NG12 (Suspected cancer), NICE CG173 (Neuropathic Pain, 2013, updated 2020), NICE NG17 (Type 1 Diabetes), NICE NG28 (Type 2 Diabetes), NICE NG33 (TB), BSSH/GIRFT carpal tunnel pathway (2022), DVLA Assessing fitness to drive, GMC Confidentiality: patients' fitness to drive (2017), Cruccu et al. EAN guidelines neuropathic pain 2017 (international), Preston DC & Shapiro BE Clinical Neurophysiology (textbook). Always adapt to individual patient context.